Moreover, SMYD3 expression was significantly negatively correlated with poor breast cancer prognosis in patients with high ZNF8 expression but not in patients with low ZNF8 expression (Figure 8E; Figure S12F, Supporting Information). Here, ZNF8 is linked to breast carcinoma.